Issues Statement in Light of Amedisys' Disclosure of Unsolicited Proposal from Optum BANNOCKBURN, Ill. , June 5, 2023 /PRNewswire/ -- Option Care Health, Inc. (" Option Care Health ") (Nasdaq: OPCH) today filed with the U.S. Securities and Exchange Commission a registration statement on Form S-4

Company to Deliver to Patients FDA-Approved Topical Treatment for Dystrophic Epidermolysis Bullosa (DEB) Announces Collaboration with Amedisys to Administer Treatment in the Home BANNOCKBURN, Ill. , May 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc.

BANNOCKBURN, Ill. , May 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: William Blair’s 43rd